Search Results - "Alberda, W.J."

Muscle wasting and survival following pre-operative chemoradiotherapy for locally advanced rectal carcinoma by Levolger, S., van Vledder, M.G., Alberda, W.J., Verhoef, C., de Bruin, R.W.F., IJzermans, J.N.M., Burger, J.W.

“…Neoadjuvant chemoradiotherapy (NACRT) has increased local control in locally advanced rectal cancer. Reduced skeletal muscle mass (sarcopenia), or ongoing…”
Get full text

109. Surgical resection of colorectal liver metastases: Does nodal status of the primary tumour have prognostic value after surgery for CRLM? by Van der Stok, E, Alberda, W.J, Reitsma, M, Rothbarth, J, Grünhagen, D.J, Verhoef, C

Get full text

Locally recurrent rectal cancer; long-term outcome of curative surgical and non-surgical treatment of 447 consecutive patients in a tertiary referral centre by Hagemans, J.A.W., van Rees, J.M., Alberda, W.J., Rothbarth, J., Nuyttens, J.J.M.E., van Meerten, E., Verhoef, C., Burger, J.W.A.

“…The majority of patients with locally recurrent rectal cancer (LRRC) present with extensive metastatic disease or an unresectable recurrence, and will be…”
Get full text

Hospital volume and outcome in rectal cancer patients; results of a population-based study in the Netherlands by Hagemans, J.A.W., Alberda, W.J., Verstegen, M., de Wilt, J.H.W., Verhoef, C., Elferink, M.A., Burger, J.W.A.

“…Clinically staged T1-3 rectal cancer (cT1-3) is generally treated by total mesorectal excision(TME) with or without neoadjuvant therapy and sometimes requires…”
Get full text